United Stateshea

GSK agreed to buy Nuvalent in a deal valued at $10.6 billion, adding a biotech firm that's developing treatments for lung cancer as the British pharmaceutical company seeks to rebuild its oncology franchise. Sam Fazeli of Bloomberg Intelligence has more.

The Ebola Bundibugyo strain is spreading fast with no known treatment or vaccine, and the international system built to contain outbreaks is in crisis. Bloomberg's Jennifer Zabasajja reports.

Click Holdings (NASDAQ:CLIK), a Hong Kong-based provider of human resources and senior care solutions, reported strong operational growth for the third quarter of its 2025/26 financial year, covering the period from January to March 2026.

A Kenyan high court instructed the authorities to disclose details of an agreement with the US government to establish an Ebola quarantine facility in the East African nation. The latest outbreak of Ebola has been concentrated in northeastern Democratic Republic of Congo and been declared a global emergency by the World Health Organization. Bloomberg's Jennifer Zabasajja reports.

Hims & Hers Health (NYSE:HIMS) has finalized the acquisition of Eucalyptus, the parent company of digital weight-management platform Juniper, marking the telehealth provider's official commercial entry into the Japanese healthcare market.

The African Development Bank is working with countries already in tight fiscal situations to provide support as the war in the Middle East carries on. African Development Bank President Dr. Sidi Ould Tah talks about that effort and the fight against the Ebola outbreak with Bloomberg's Jennifer Zabasajja.

USAID's closure placed millions of lives at risk, studies show. Donald Trump's new program requires minerals and data as a price of aid. In Mozambique, clinics now face hard choices as Ebola spreads.

Ebola is spreading faster in Democratic Republic of Congo than responders can contain it, the World Health Organization warned, as suspected deaths climbed above 220 and treatment centers came under attack in the country's conflict-hit east. The crisis has drawn about $500 million in global pledges. Bloomberg's Janice Kew reports.

Insilico Medicine Founder & CEO Alex Zhavoronkov discusses how his company aims to apply artificial intelligence to revolutionize drug discovery and longevity research. He speaks with Haslinda Amin from the sidelines of 'JPMorgan Global China Summit' in Shanghai.

World Health Organization Director-General Tedros Adhanom Ghebreyesus called for an international response to the Ebola outbreak at a meeting of the WHO's emergency committee in Geneva on Tuesday. Bloomberg's Jennifer Zabasajja reports.